2 completed, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Paclitaxel protein bound: new trials by email Literature Review of Paclitaxel protein bound trials Research Report on Paclitaxel protein bound
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer Carboplatin, Paclitaxel, Pembrolizumab - Stage 1 cT1b-T1cN0M0, Triple Negative Breast Cancer | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 28 | 2024-05-29 | 2026-03-04 |
| Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer Paclitaxel protein bound, Gemcitabine, Cisplatin - Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma | Phase 2 | Completed | HonorHealth Research Institute | 19 | 2020-12-01 | 2026-07-21 |
| Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma Paclitaxel protein bound, Cisplatin, Gemcitabine - Pancreatic Cancer | Phase 2 | Completed | Barts & The London NHS Trust | 27 | 2018-11-29 | 2025-11-21 |
Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Barts & The London NHS Trust (1) · HonorHealth Research Institute (1) · M.D. Anderson Cancer Center (1)
United States (2) · United Kingdom (1)
Erkut Borazanci, MD (1) · Oluchi Oke, MD (1)